Orthofix International | OFIX - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 84.55M 6.21M 2026-03
Dexcom USD 349.7M 49.8M 2026-03
EDAP TMS EUR 8.81M 1.57M 2025-09
Globus Medical USD 297.77M 20.7M 2026-03
Inogen USD 43.77M 510K 2024-06
Insulet USD 317.2M 14.2M 2026-03
Integra LifeSciences USD 178.24M 21.79M 2026-03
J&J USD 6.03B 719M 2026-03
Medtronic 2.96B 9M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Orthofix International USD 130.35M 11.31M 2025-12
Plus Therapeutics USD 3.49M 559K 2025-12
Smith & Nephew USD 1.42B 65M 2025-12
STAAR Surgical USD 38.64M 299K 2026-03
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 226.01M 3.64M 2026-03
Veracyte USD 50.84M 7.53M 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03